Enrico Castellucci

https://assets.montefioreeinstein.org/profiles/images/physphoto/Castellucci_Enrico_MD_420x504.jpg

First Name

Enrico

Last Name

Castellucci

NPI

1821354622

Faculty ID

17784

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

76764

Is Open Scheduling

Off

Henny H. Billett

https://assets.montefioreeinstein.org/profiles/images/physphoto/Billett_Henny_MD_420x504.jpg

First Name

Henny

Last Name

Billett

NPI

1689755001

Faculty ID

6411

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Henny Billett has been Chief of the Division of Hematology since 2012 and Professor of Clinical Medicine and Pathology since 2002.</p>
<p>Dr. Billett's clinical research interests are in risk factors for thrombosis and microvascular disease, with emphasis on epidemiological aspects and outcomes research.</p>
<p>Recent investigations have focused on:</p>
<ol>
<li>Hemolysis patterns in CF-LVAD patients and their association with device thrombosis (collaboration with Dr. Ulrich Jorde, Cardiology)</li>
<li>Evaluation of CNS function and cognition in patients with sickle cell disease (collaboration with Dr. Craig Branch, Gruss Magnetic Resonance Research Center)</li>
<li>Priapism in murine and human models of sickle cell (collaboration with Dr. Kelvin Davies)</li>
<li>Multicenter studies
<ul>
<li>P-Selectin therapy in sickle cell disease</li>
<li>Viral co-infections, paraproteinemia and thrombosis</li>
</ul>
</li>
</ol>
<p>Dr. Billett completed an undergraduate degree from the University of Pennsylvania cum laude; medical school Mount Sinai School of Medicine; and an MSc from the London School of Hygiene and Tropical Medicine in London. She was a Senior House Officer at St. Bartholomew's Hospital, London, and completed her training at Montefiore.</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<ol>
<li>Park D, Southern W, Calvo M, Kushnir M, Solorzano C, Sinnett M, <strong>Billett HH</strong>. Treatment with Dalteparin is Associated with a Lower Risk of Bleeding Compared to Treatment with Unfractionated Heparin in Patients with Renal Insufficiency. J Gen Intern Med. 2016; 31(2):182-7. PubMed [journal]PMID: 26209179 PMCID: PMC4720650</li>
<li>Jou, E, Glichich G, Chan ACY, Mohan D, Felson UR, Ayyappan S, <strong>Billett HH</strong>, Hui E, Chan ATC, Raghupathy R. Viral Co-Infections and Paraproteins in HIV: Effect on Development of Hematological Malignancies. Ann Hematol. 2016 Jan 9. [Epub ahead of print] PMID: 26747296</li>
<li>Broder A, Mowrey W, Kim M, Murakhovskaya I, <strong>Billett HH</strong>, Neugarten J, Costenbader KH, Putterman C.Association between Antiphospholipid Antibodies and All-Cause Mortality among End-Stage Renal Disease Patients with and without SLE: a retrospective cohort study. Rheumatology 2015 Dec 24. pii: kev423. [Epub ahead of print] PubMed PMID: 26705328.&nbsp;</li>
<li>Naymagon H, Pendurti G, <strong>Billett HH</strong>. Acute Splenic sequestration crisis in adult sickle cell disease: A report of 16 cases. Hemoglobin. 2015;39:375-9.</li>
<li>Curtis SA, Etzion Z, Danda NA, Cohen HW, <strong>Billett HH</strong>. Elevated steady state WBC and platelet counts are associated with frequent emergency room use in adults with sickle cell anemia. PLoS One.</li>
</ol>

EMR ID

3198

Is Open Scheduling

Off

Steven Ira Berk

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/df190570-5e8e-11ee-94fb-7b66b01a7494.jpg

First Name

Steven

Last Name

Berk

NPI

1265522031

Faculty ID

5237

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Provider Type

Primary Care

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Primary Care</p>
<p>General Internal Medicine</p>
<p>Clinical Pharmacology</p>
<p>Drug Interactions</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

4209

Is Open Scheduling

On

Jesus D. Anampa Mesias

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/f27dbf80-2ee1-11ed-bcda-4d15024a9ee0.jpg

First Name

Jesus

Last Name

Anampa Mesias

NPI

1356590772

Faculty ID

14446

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. Jesus Anampa is an Associate Professor of Medicine in the Department of Medical Oncology at Albert Einstein College of Medicine/ Montefiore Medical Center. Dr. Anampa is the Clinical Research Leader for Breast Oncology at Montefiore Medical Center and The Phase I Liaison for Breast Oncology.</span></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">A native of Peru, Dr. Anampa finished medical school at Universidad Peruana Cayetano Heredia in Lima, Peru, and successfully finished Internal Medicine Residency at Rochester General Hospital in Rochester, NY. Dr. Anampa initially joined Albert Einstein College of Medicine/Montefiore Medical Center to complete his fellowship in hematology/oncology and then joined our medical oncology faculty team at AECOM/MMC. In 2018, he obtained a Master&rsquo;s of Science degree &ldquo;with distinction&rdquo; in clinical research from Albert Einstein College of Medicine. Dr. Anampa is a practicing physician who specializes in breast medical oncology and clinical &amp; translational cancer research.&nbsp;</span></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">&nbsp;</span></p>
<p><strong><u><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Tumor MicroEnvironment of Metastasis</span></u></strong><u></u></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. Anampa is currently working with the tumor microenvironment (TME) program at Albert Einstein College of Medicine, which is a nationwide well-recognized program, lead by Dr. John Condeelis, evaluating new mechanisms of cancer intravasation and dissemination. Dr. Anampa plays an important role in translating bench-to-bedside and bedside-to-bench research in our TME program, and currently, he is working on the Tumor microenvironment of metastasis (TMEM) and its significance as a biomarker in breast cancer. Dr. Anampa is the principal investigator of a novel phase I trial targeting the tumor microenvironment to prevent metastasis. In addition, Dr. Anampa is leading a clinical trial to validate a novel imaging technique to identify metastasis doorways (TMEM) in vivo using MRI in patients with breast cancer.</span></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;"><a href="https://clinicaltrials.gov/ct2/show/NCT03694756">https://clinicaltrials…;
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;"><a href="https://clinicaltrials.gov/ct2/show/NCT02824575">https://clinicaltrials…;
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">&nbsp;</span></p>
<p><strong><u><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Breast Cancer and Obesity</span></u></strong><u></u></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. Anampa is working with the diabetes center at Albert Einstein to identify pathways associated with obesity and breast cancer. Preclinical studies at our institution have demonstrated that the CDK4/6-Rb pathway is affected in diet-induced obesity in mouse models. Dr. Anampa is leading a clinical trial that assesses the effect of CDK 4/6 inhibitors on body composition in patients with metastatic breast cancer.</span></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;"><a href="https://clinicaltrials.gov/ct2/show/NCT03697577">https://clinicaltrials…;
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">&nbsp;</span></p>
<p><strong><u><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Clinical/Translational Research Leadership</span></u></strong><u></u></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. Anampa is The Clinical Research Leader for Breast Oncology at Montefiore Medical Center/AECOM and he serves as local principal investigator for several Phase I, II, and III trials. In addition, Dr. Anampa is also a member of the Protocol Review and monitoring committee at Montefiore Medical Center/AECOM.</span></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. Anampa serves as the Montefiore Principal Investigator for the Translational Breast Cancer Research symposium (TBCRC) and the (I-Spy2)</span></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. Anampa is a native Spanish-speaker and has an innate passion for breast cancer research, with an ultimate goal to expand breast cancer therapeutic options and improve breast cancer outcomes. Dr. Anampa is also interested in breast cancer research and is always eager to participate in community activities related to breast cancer.</span></p>
<p>&nbsp;</p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">During his free time, Dr. Anampa enjoys mountain biking and soccer.</span></p>

Research Areas

Specialties

Expert Tags

Areas of Expertise

Expert Summary

<p>Dr. Anampa is a breast medical oncologist and a member of the Tumor Microenvironment and Metastasis (TMEM) research program at Albert Einstein College of Medicine, which focuses on targeting the tumor microenvironment as a mechanism to prevent the spread of breast cancer.
He is fluent in Spanish and enjoys participating in bilingual community activities about cancer prevention and treatment in the Bronx.</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Breast cancer, medical oncology, clinical trials

Research Focus

Tumor micro-environment of metastasis and breast cancer; breast cancer immunology, new mechanisms of metastasis, cancer among minorities, breast cancer risk and outcomes among women with HIV

Elsevier Profile

EMR ID

56774

Biography

<p>Jesus Anampa Mesias, MD is a medical oncologist at Montefiore Einstein Comprehensive Cancer Center and a member of its Cancer Therapeutics Research Program focused on identifying new treatment targets and novel cancer therapeutics. He is fluent in Spanish and enjoys participating in bilingual community activities about cancer prevention and treatment in our community.</p><p>Dr. Anampa Mesias received his medical degree from the Universidad Peruana Cayetano Heredia in Lima, Peru, completed his residency in internal medicine at Rochester General Hospital in Rochester, NY, and completed a medical oncology/clinical hematology fellowship at Montefiore Medical Center. He remained at Albert Einstein as a research fellow before joining the medical oncology team at Montefiore.</p><p> </p>

Is Open Scheduling

Off